Efficacy and Safety of Anlotinib Combined with Second-line Chemotherapy in the Treatment of Advanced Small Cell Lung Cancer

CUI Xuefang, RONG Feifei, LI Hongjie, XIANG Zaidong, WANG Luyan, CAI Renping

PDF(1346 KB)
PDF(1346 KB)
Chinese And Foreign Medical Research ›› 2023, Vol. 21 ›› Issue (6) : 112-116. DOI: 10.14033/j.cnki.cfmr.2023.06.028
Experience

Efficacy and Safety of Anlotinib Combined with Second-line Chemotherapy in the Treatment of Advanced Small Cell Lung Cancer

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2023, 21(6): 112-116 https://doi.org/10.14033/j.cnki.cfmr.2023.06.028

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(1346 KB)

Accesses

Citation

Detail

Sections
Recommended

/